Evaluation of Serum Human Epididymis Secretory Protein 4 (HE4) in Benign Endometrial Disease and Endometrial Cancer
Fatma Mohammed Abukra;
Abstract
Endometrial cancer is one of the most important leading causes of cancer deaths among women.
Endometrial cancer is the seventh most commonly diagnosed gynecologic malignancy in the United States.
In recent years, several articles have been published about HE4 as a new tumor marker used in diagnosis of endometrial cancer and predict EC staging
In the current study, we evaluate the ability of serum HE4 concentration to differentiate between benign endometrial lesions and endometrial cancer. And asses correlation it with prognosis of EC.
The present study was carried out at Ain shams University Maternity Hospital, Gynecologic Hospitalized patients during the period from Decamber2017 up to June 2018.
Endometrial cancer is the seventh most commonly diagnosed gynecologic malignancy in the United States.
In recent years, several articles have been published about HE4 as a new tumor marker used in diagnosis of endometrial cancer and predict EC staging
In the current study, we evaluate the ability of serum HE4 concentration to differentiate between benign endometrial lesions and endometrial cancer. And asses correlation it with prognosis of EC.
The present study was carried out at Ain shams University Maternity Hospital, Gynecologic Hospitalized patients during the period from Decamber2017 up to June 2018.
Other data
| Title | Evaluation of Serum Human Epididymis Secretory Protein 4 (HE4) in Benign Endometrial Disease and Endometrial Cancer | Other Titles | تقييم مستوى مصل بروتين البربخ البشري في حالات سرطان بطانة الرحم وحالات بطانة الرحم الحميدة | Authors | Fatma Mohammed Abukra | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.